Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Akorn | Location not on file | Makes it, tests it, packages it, labels it and sterilizes it | Not inspected on record |
Recalls
- Oct 13, 2022 · Class II · Akorn, Inc.
CGMP Deviations:
Lots: Lot: 0L48A, EXP 10/31/2022; 0L55A, EXP 10/31/2022; 1C75A, EXP 2/28/2023; 1E18A, 1E20A , EXP 4/30/2023;
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Olopatadine: every company that makes it
- Form
- solution/ drops
- Strength
- 2 mg per 1 mL
- Approval
- ANDA ANDA204723
- On the market since
- Dec 5, 2017
- Package NDCs
17478-305-12- Official label
- DailyMed (National Library of Medicine), updated Feb 3, 2022
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?